Riskpilot← Back to searchSign inGet full accessBMJ Sanering AB
ABDissolvedOrg 5592421746Demolition · NACE 4311Est. 20202 employees
Revenue 2023
SEK 24,2M
+3% vs 2022
EBITDA margin
8.2%
-24% vs 2022
Equity ratio
48.0%
Financial strength
Net profit 2023
SEK 1,5M
-4% vs 2022
| Revenue | SEK 24,2M | +3% |
| EBITDA | SEK 2M | -24% |
| Net profit | SEK 1,5M | -4% |
| Total assets | SEK 8,5M | -13% |
| Equity | SEK 4,1M | +48% |
| Employees | 2 | — |
Legal name
BMJ Sanering AB
Org number
5592421746
Legal form
Aktiebolag
NACE code
4311 · Demolition
Founded
13 februari 2020
Share capital
SEK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska sanera asbest, industri och fastighetssanering, samt transporter i anslutning därtill och därmed förenlig verksamhet. Bolaget skall även bedriva konsultverksamhet inom redovisning och arbetsledning.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 9 154 | 23 433 | 24 240 |
| Staff expenses | — | −4 044 | −5 027 |
| EBITDA | 2 273 | 2 643 | 1 997 |
| Depreciation & amort. | −0 | — | −85 |
| EBIT | 2 273 | 2 643 | 1 912 |
| Net financials | — | −0 | −4 |
| Profit before tax | 1 703 | 1 983 | 1 908 |
| Tax | −367 | −409 | −399 |
| Net profit | 1 336 | 1 574 | 1 509 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 4 661 | 9 804 | 8 494 |
| Equity | 1 366 | 2 756 | 4 078 |
| Long-term debt | 0 | — | — |
| Short-term debt | 2 725 | 5 817 | 3 187 |
| Total debt | 2 725 | 5 817 | 3 187 |
EBITDA margin
8.2%
This company
15.8%
Market median
-48% vs market
20212023
Equity ratio
48.0%
This company
38.2%
Market median
+26% vs market
20212023
Return on equity
37.0%
This company
18.4%
Market median
+101% vs market
20212023
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20212023
Asset turnover
2.85×
This company
1.12×
Market median
+154% vs market
20212023
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20212023
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MM | Audit | 2022 |
CN Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BMJ Sanering AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maggie Margaretha Fagergren | Audit | 0 companies |
| Carl-Magnus Nyman | Chief Executive Officer | 0 companies |
| Eric Patrik Lennart Arn Svensson | Chairman | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Lars Jesper Johansson | Board of Directors | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |